A single arm open label study to evaluate the pharmacodynamics and safety of a 4 wk treatment with BI 144807 in patients with newly diagnosed age related macular degenaration (wAMD)
Basic data for this project
Type of project: Individual project
Duration at the University of Münster: 01/07/2014 - 01/07/2015
Description
Keywords: Klinische Studie; Boehringer AMD
Funding identifier: wetAMD 1313.20
Funder / funding scheme:
- Boehringer Ingelheim Pharma GmbH & Co. KG
Project management at the University of Münster
| Eter, Nicole | Clinic for Ophthalmology |
Applicants from the University of Münster
| Eter, Nicole | Clinic for Ophthalmology |